[1] |
Donovan J, Figaji A, Imran D, et al. The neurocritical care of tuberculous meningitis[J]. Lancet Neurol, 2019,18(8):771-783.
|
[2] |
中华医学会结核病学分会结核性脑膜炎专业委员会. 2019中国中枢神经系统结核病诊疗指南[J]. 中华传染病杂志,2020,38(7):400-408.
|
[3] |
Organization WH (2021). Tuberculosis deaths rise for the first time in more than a decade due to the COVID-19 pandemic[EB/OL]. 2021.
URL
|
[4] |
Organization WH (2019). World Health Statistics 2019: Monitoring health for the SDGs, sustainable development goals[EB/OL]. 2019.
URL
|
[5] |
Schaller MA, Wicke F, Foerch C, et al. Central nervous system tuberculosis: etiology, clinical manifestations and neuroradiological features[J]. Clin Neuroradiol,2019,29(1):3-18.
|
[6] |
Navarro-Flores A, Fernandez-Chinguel JE, Pacheco-Barrios N, et al. Global morbidity and mortality of central nervous system tuberculosis: a systematic review and meta-analysis[J]. J Neurol, 2022,269(7):3482-3494.
|
[7] |
Centers for Disease Control and Prevention. Reported tuberculosis in the United States, 2018[EB/OL]. 2019.
URL
|
[8] |
Pang Y, An J, Shu W, et al. Epidemiology of extrapulmonary tuberculosis among inpatients, China. 2008-2017[J]. Emerg Infect Dis,2019,25(3):457-464.
|
[9] |
Basu Roy R, Thee S, Blázquez-Gamero D, et al. Performance of immune-based and microbiological tests in children with tuberculosis meningitis in Europe: a multicentre Paediatric Tuberculosis Network European Trials Group (ptbnet) study[J]. Eur Respir J,2020,56(1):1902004.
|
[10] |
Thwaites GE, Chau TT, Farrar JJ. Improving the bacteriological diagnosis of tuberculous meningitis[J]. J Clin Microbiol, 2004,42(1):378-379.
|
[11] |
Erdem H, Ozturk-Engin D, Elaldi N, et al. The microbiological diagnosis of tuberculous meningitis of Haydarpasa-1 study[J]. Clin Microbiol Infect,2014,20(10):O600-O608.
|
[12] |
Kennedy DH, Fallon RJ. Tuberculous meningitis[J]. JAMA,1979, 241(3):264-268.
|
[13] |
Hernandez AV, Laurentis L, Souza I, et al. Diagnostic accuracy of Xpert MTB/RIF for tuberculous meningitis: systematic review and meta-analysis[J]. Trop Med Int Health,2021,26(2):122-132.
|
[14] |
Donovan J, Cresswell FV, Thuong NTT, et al. Xpert MTB/RIF ultra for the diagnosis of tuberculous meningitis: A small step forward[J]. Clin Infect Dis,2020,71(8):2002-2005.
|
[15] |
Chen Y, Wang Y, Liu X, et al. Comparative diagnostic utility of metagenomic next-generation sequencing, GeneXpert, modified Ziehl-Neelsen staining, and culture using cerebrospinal fluid for tuberculous meningitis: A multi-center, retrospective study in China[J]. J Clin Lab Anal,2022,36(4):e24307.
|
[16] |
Ramachandran PS, Ramesh A, Creswell FV, et al. Integrating central nervous system metagenomics and host response for diagnosis of tuberculosis meningitis and its mimics[J]. Nat Commun,2022,13(1):1675.
|
[17] |
Wilson MR, Sample HA, Zorn KC, et al. Clinical metagenomic sequencing for diagnosis of meningitis and encephalitis[J]. N Engl J Med,2019,380(24):2327-2340.
|
[18] |
林爱清, 张璐, 成宝涛, 等. 二代测序技术应用于脑脊液检测在结核性脑膜炎中的早期诊断价值[J/CD]. 中华实验和临床感染病杂志(电子版),2020,14(4):291-295.
|
[19] |
Arai M, Inaba R. A case of tuberculous meningitis with pleural effusion as a manifestation of a paradoxical reaction during anti-tuberculosis therapy[J]. Rinsho Shinkeigaku,2019,59(8):541-544.
|
[20] |
Pepper DJ, Marais S, Maartens G, et al. Neurologic manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome: a case series[J]. Clin Infect Dis,2009,48(11): e96-e107.
|
[21] |
徐勇胜. 结核病治疗中的矛盾反应[J]. 中华实用儿科临床杂志,2019,34(9):646-649.
|
[22] |
Liu Y, Wang Z, Yao G, et al. Paradoxical reaction in HIV-negative tuberculous meningitis patients with spinal involvement[J]. Int J Infect Dis,2019,79:104-108.
|
[23] |
Nahid P, Dorman SE, Alipanah N, et al. Official American thoracic society/centers for disease control and prevention/infectious diseases society of America clinical practice guidelines: treatment of drug-susceptible tuberculosis[J]. Clin Infect Dis,2016,63(7):e147-e195.
|
[24] |
Lee JY. Diagnosis and treatment of extrapulmonary tuberculosis[J]. Tuberc Respir Dis (Seoul),2015,78(2):47-55.
|
[25] |
Ravimohan S, Tamuhla N, Nfanyana K, et al. Robust reconstitution of tuberculosis-specifc polyfunctional CD4+ T-cell responses and rising systemic interleukin 6 in paradoxical tuberculosis-associated immune reconstitution infammatory syndrome[J]. Clin Infect Dis,2016,62(6):795-803.
|
[26] |
中华医学会结核病学分会. 结核病免疫治疗专家共识(2022年版)[J]. 中华结核和呼吸杂志,2022,45(7):651-666.
|
[27] |
Armange L, Lacroix A, Petitgas P, et al. The use of TNF-α antagonists in tuberculosis to control severe paradoxical reaction or immune reconstitution inflammatory syndrome: a case series and literature review[J]. Eur J Clin Microbiol Infect Dis,2023,42(4):413-422.
|
[28] |
Abo YN, Curtis N, Osowicki J, et al. Infliximab for paradoxical reactions in pediatric central nervous system tuberculosis[J]. J Pediatric Infect Dis Soc,2021,10(12):1087-1091.
|
[29] |
Marais BJ, Cheong E, Fernando S, et al. Use of infliximab to treat paradoxical tuberculous meningitis reactions[J]. Open Forum Infect Dis,2020,8(1):ofaa604.
|
[30] |
Garg RK, Malhotra HS, Kumar N. Paradoxical reaction in HIV negative tuberculous meningitis[J]. J Neurol Sci,2014,340(1-2):26-36.
|